Project Grant K99AI180649
Award Date
6/14/24
Completion Date
5/31/26
Dollars Obligated
$257K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This federal Project Grant award, with ID R01AI179712, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855).
The approximately $857,346 award will fund research by the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) to investigate how activating and inhibitory signals in the form of cytokines and metabolites present in healthy human tissues regulate the effector...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $231,752 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) to investigate the in vivo innate immune response to HIV-1 infection. The research aims to identify the cellular sources of cytokines released during acute HIV-1 infection and determine the functional roles of different innate immune...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $128,250 to the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) to develop safer and more specific chimeric antigen receptor (CAR) T cell therapies targeting the PD-1 immune checkpoint protein. The goal is to eliminate HIV-infected CD4 T follicular helper cells within B cell follicles, which serve as a...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the role of cells, antigens, and antibodies in controlling virus infections through antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytolysis (CDC). The $318,085 award, running from December 2024 to November 2029, aims...
This federal Project Grant award of $153,512 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to characterize the Circumsporozoite Protein (CSP)-specific memory B cell pool generated during Plasmodium infection or immunization in a murine model and relevant human clinical trial samples. The research objective is to understand how previous Plasmodium infection impacts the response to subsequent vaccination, and to...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $114,722 to Sloan-Kettering Institute For Cancer Research to investigate the molecular basis of the context-dependent role of the STAT3 transcription factor in natural killer (NK) cells during viral infections. The research aims to 1) determine how different upstream signals alter STAT3's impact on NK cell...
This $530,015 federal Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) supports research at the Fred Hutchinson Cancer Center in Seattle, Washington to investigate the immunomodulatory effects of natural killer (NK) cells on anti-tumor immune responses. The overarching goal is to define the cellular and molecular mechanisms regulating NK cell phenotype and function in the tumor microenvironment, with a specific focus on understanding how...
This $148,568 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support a research study to investigate how viruses can evade or co-opt innate immune peptides called defensins to enhance their infectivity. The key objectives are to:
Determine the structural and biochemical properties of defensins essential for their antiviral activity against human adenovirus, rotavirus, and human...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $829,396 to the University of Washington to investigate the role of intestinal microfold (M) cells in creating an environment that fosters persistence and reactivation of the HIV reservoir. The project aims to:
Examine whether interaction with M cells increases immune activation of bystander CD4+ T cells and macrophages using...
This federal Project Grant award in the amount of $1,179,316.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award is focused on understanding the mechanisms that regulate CD8 T cell responses during chronic viral infection, with the goal of improving immunotherapies to increase T cell function and reduce viral load. Key aspects of the research include:
Determining the role of...